Mario Gabelli Opiant Pharmaceuticals, Inc. Transaction History

Gamco Investors, Inc. Et Al

  • $9 Billion
  • Q3 2024

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$9.38 - $20.29 $93,800 - $202,900
10,000 New
10,000 $202,000

Others Institutions Holding OPNT

# of Institutions
2
Shares Held
300
Call Options Held
0
Put Options Held
0
View Full List

About OPIANT PHARMACEUTICALS, INC.

OPNT Quotes by TradingView
  • Ticker OPNT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,164,150
  • Description
  • Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...
More about OPNT
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email